{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T08:55:42Z","timestamp":1790931342792,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["RYC2023-043746-I"],"award-info":[{"award-number":["RYC2023-043746-I"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["CNS2024-154295"],"award-info":[{"award-number":["CNS2024-154295"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PMP22\/00022, PI20\/01011, PI24\/00089, TED2021-131676B-100"],"award-info":[{"award-number":["PMP22\/00022, PI20\/01011, PI24\/00089, TED2021-131676B-100"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Reina Sofia Foundation","award":["E.6.4 FRS-CUERPOS DE LEWY"],"award-info":[{"award-number":["E.6.4 FRS-CUERPOS DE LEWY"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00259-026-08093-w","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T06:52:01Z","timestamp":1784530321000},"page":"7504-7513","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["[18F]FDG PET outperforms MRI for detecting early tau-related neurodegeneration"],"prefix":"10.1007","volume":"53","author":[{"given":"Orfeas","family":"Vourkas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"Jimenez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"S\u00e1nchez-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Fern\u00e1ndez-\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Rabano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascual","family":"S\u00e1nchez-Juan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Silva-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2600-9022","authenticated-orcid":false,"given":"Michel J.","family":"Grothe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Alzheimer\u2019s Disease Neuroimaging Initiative","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"8093_CR1","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","volume":"12","author":"CR Jack","year":"2013","unstructured":"Jack CR, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, et al. Tracking pathophysiological processes in Alzheimer\u2019s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013;12:207\u201316. https:\/\/doi.org\/10.1016\/S1474-4422(12)70291-0.","journal-title":"Lancet Neurol"},{"key":"8093_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjpad.2025.100447","volume":"13","author":"CJ Mummery","year":"2026","unstructured":"Mummery CJ, Li-Hsian CC, Lasagna-Reeves CA, Ossenkoppele R, Rowe CC, Scharre DW, et al. Tau in Alzheimer\u2019s disease: shaping the future patient journey. J Prev Alzheimers Dis. 2026;13:100447. https:\/\/doi.org\/10.1016\/j.tjpad.2025.100447.","journal-title":"J Prev Alzheimers Dis"},{"key":"8093_CR3","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0197-4580(95)00021-6","volume":"16","author":"H Braak","year":"1995","unstructured":"Braak H, Braak E. Staging of Alzheimer\u2019s disease-related neurofibrillary changes. Neurobiol Aging. 1995;16:271\u20138. https:\/\/doi.org\/10.1016\/0197-4580(95)00021-6. discussion 278\u2013284.","journal-title":"Neurobiol Aging"},{"key":"8093_CR4","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1093\/brain\/awv236","volume":"138","author":"H Braak","year":"2015","unstructured":"Braak H, Del Tredici K. The preclinical phase of the pathological process underlying sporadic Alzheimer\u2019s disease. Brain. 2015;138:2814\u201333. https:\/\/doi.org\/10.1093\/brain\/awv236.","journal-title":"Brain"},{"key":"8093_CR5","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1093\/brain\/awx243","volume":"140","author":"A Bejanin","year":"2017","unstructured":"Bejanin A, Schonhaut DR, La Joie R, Kramer JH, Baker SL, Sosa N, et al. Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer\u2019s disease. Brain. 2017;140:3286\u2013300. https:\/\/doi.org\/10.1093\/brain\/awx243.","journal-title":"Brain"},{"key":"8093_CR6","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/alz.13355","volume":"20","author":"C Boccalini","year":"2024","unstructured":"Boccalini C, Ribaldi F, Hristovska I, Arnone A, Peretti DE, Mu L, et al. The impact of tau deposition and hypometabolism on cognitive impairment and longitudinal cognitive decline. Alzheimers Dement. 2024;20:221\u201333. https:\/\/doi.org\/10.1002\/alz.13355.","journal-title":"Alzheimers Dement"},{"key":"8093_CR7","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1093\/brain\/awad346","volume":"147","author":"J Lee","year":"2024","unstructured":"Lee J, Burkett BJ, Min H-K, Senjem ML, Dicks E, Corriveau-Lecavalier N, et al. Synthesizing images of tau pathology from cross-modal neuroimaging using deep learning. Brain. 2024;147:980\u201395. https:\/\/doi.org\/10.1093\/brain\/awad346.","journal-title":"Brain"},{"key":"8093_CR8","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1007\/s00259-018-4027-y","volume":"45","author":"F Nobili","year":"2018","unstructured":"Nobili F, Schmidt R, Carri\u00f2 I, Frisoni GB. Brain FDG-PET: clinical use in dementing neurodegenerative conditions. Eur J Nucl Med Mol Imaging. 2018;45:1467\u20139. https:\/\/doi.org\/10.1007\/s00259-018-4027-y.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"8093_CR9","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"CR Jack","year":"2024","unstructured":"Jack CR, Andrews JS, Beach TG, Buracchio T, Dunn B, Graf A, et al. Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup. Alzheimers Dement. 2024;20:5143\u201369. https:\/\/doi.org\/10.1002\/alz.13859.","journal-title":"Alzheimers Dement"},{"key":"8093_CR10","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41583-018-0067-3","volume":"19","author":"W Jagust","year":"2018","unstructured":"Jagust W. Imaging the evolution and pathophysiology of Alzheimer disease. Nat Rev Neurosci. 2018;19:687\u2013700. https:\/\/doi.org\/10.1038\/s41583-018-0067-3.","journal-title":"Nat Rev Neurosci"},{"key":"8093_CR11","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/s0306-4522(99)00476-5","volume":"95","author":"M Bobinski","year":"2000","unstructured":"Bobinski M, de Leon MJ, Wegiel J, Desanti S, Convit A, Saint Louis LA, et al. The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer\u2019s disease. Neuroscience. 2000;95:721\u20135. https:\/\/doi.org\/10.1016\/s0306-4522(99)00476-5.","journal-title":"Neuroscience"},{"key":"8093_CR12","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.neurobiolaging.2005.04.011","volume":"27","author":"B Delatour","year":"2006","unstructured":"Delatour B, Gu\u00e9gan M, Volk A, Dhenain M. In vivo MRI and histological evaluation of brain atrophy in APP\/PS1 transgenic mice. Neurobiol Aging. 2006;27:835\u201347. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2005.04.011.","journal-title":"Neurobiol Aging"},{"key":"8093_CR13","first-page":"1920","volume":"41","author":"JM Hoffman","year":"2000","unstructured":"Hoffman JM, Welsh-Bohmer KA, Hanson M, Crain B, Hulette C, Earl N, et al. FDG PET imaging in patients with pathologically verified dementia. J Nucl Med Off Publ Soc Nucl Med. 2000;41:1920\u20138.","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"key":"8093_CR14","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1016\/j.neuroimage.2003.07.002","volume":"20","author":"AB Rocher","year":"2003","unstructured":"Rocher AB, Chapon F, Blaizot X, Baron J-C, Chavoix C. Resting-state brain glucose utilization as measured by PET is directly related to regional synaptophysin levels: a study in baboons. NeuroImage. 2003;20:1894\u20138. https:\/\/doi.org\/10.1016\/j.neuroimage.2003.07.002.","journal-title":"NeuroImage"},{"key":"8093_CR15","doi-asserted-by":"publisher","first-page":"e14582","DOI":"10.1002\/alz.14582","volume":"21","author":"LEM Wisse","year":"2025","unstructured":"Wisse LEM, Wuestefeld A, Murray ME, Jagust W, La Joie R. Role of tau versus TDP-43 pathology on medial temporal lobe atrophy in aging and Alzheimer\u2019s disease. Alzheimers Dement. 2025;21:e14582. https:\/\/doi.org\/10.1002\/alz.14582.","journal-title":"Alzheimers Dement"},{"key":"8093_CR16","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1212\/01.wnl.0000324924.91351.7d","volume":"71","author":"JL Whitwell","year":"2008","unstructured":"Whitwell JL, Josephs KA, Murray ME, Kantarci K, Przybelski SA, Weigand SD, et al. MRI correlates of neurofibrillary tangle pathology at autopsy: a voxel-based morphometry study. Neurology. 2008;71:743\u20139. https:\/\/doi.org\/10.1212\/01.wnl.0000324924.91351.7d.","journal-title":"Neurology"},{"key":"8093_CR17","doi-asserted-by":"publisher","first-page":"e1301","DOI":"10.1212\/WNL.0000000000010192","volume":"95","author":"SJ Teipel","year":"2020","unstructured":"Teipel SJ, Fritz H-C, Grothe MJ, Alzheimer\u2019s Disease Neuroimaging Initiative. Neuropathologic features associated with basal forebrain atrophy in Alzheimer disease. Neurology. 2020;95:e1301-11. https:\/\/doi.org\/10.1212\/WNL.0000000000010192.","journal-title":"Neurology"},{"key":"8093_CR18","doi-asserted-by":"publisher","first-page":"855","DOI":"10.2967\/jnumed.120.252783","volume":"62","author":"G Blazhenets","year":"2021","unstructured":"Blazhenets G, Frings L, S\u00f6rensen A, Meyer PT, Alzheimer\u2019s Disease Neuroimaging Initiative. Principal-component analysis-based measures of PET data closely reflect neuropathologic staging schemes. J Nucl Med. 2021;62:855\u201360. https:\/\/doi.org\/10.2967\/jnumed.120.252783.","journal-title":"J Nucl Med"},{"key":"8093_CR19","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.jalz.2019.03.016","volume":"15","author":"VJ Lowe","year":"2019","unstructured":"Lowe VJ, Lundt ES, Albertson SM, Przybelski SA, Senjem ML, Parisi JE, et al. Neuroimaging correlates with neuropathologic schemes in neurodegenerative disease. Alzheimers Dement. 2019;15:927\u201339. https:\/\/doi.org\/10.1016\/j.jalz.2019.03.016.","journal-title":"Alzheimers Dement"},{"key":"8093_CR20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1212\/WNL.0b013e3181cb3e25","volume":"74","author":"RC Petersen","year":"2010","unstructured":"Petersen RC, Aisen PS, Beckett LA, Donohue MC, Gamst AC, Harvey DJ, et al. Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI): clinical characterization. Neurology. 2010;74:201\u20139. https:\/\/doi.org\/10.1212\/WNL.0b013e3181cb3e25.","journal-title":"Neurology"},{"key":"8093_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","volume":"123","author":"TJ Montine","year":"2012","unstructured":"Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, et al. National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: a practical approach. Acta Neuropathol (Berl). 2012;123:1\u201311. https:\/\/doi.org\/10.1007\/s00401-011-0910-3.","journal-title":"Acta Neuropathol (Berl)"},{"key":"8093_CR22","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/(SICI)1097-0193(","volume":"7","author":"J Ashburner","year":"1999","unstructured":"Ashburner J, Friston KJ. Nonlinear spatial normalization using basis functions. Hum Brain Mapp. 1999;7:254\u201366. https:\/\/doi.org\/10.1002\/(SICI)1097-0193(. 1999)7:4&%23x0003c;254::AID-HBM4&%23x0003e;3.0.CO;2-G.","journal-title":"Hum Brain Mapp"},{"key":"8093_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2020.117229","volume":"222","author":"FJ L\u00f3pez-Gonz\u00e1lez","year":"2020","unstructured":"L\u00f3pez-Gonz\u00e1lez FJ, Silva-Rodr\u00edguez J, Paredes-Pacheco J, Ni\u00f1erola-Baiz\u00e1n A, Efthimiou N, Mart\u00edn-Mart\u00edn C, et al. Intensity normalization methods in brain FDG-PET quantification. Neuroimage. 2020;222:117229. https:\/\/doi.org\/10.1016\/j.neuroimage.2020.117229.","journal-title":"Neuroimage"},{"key":"8093_CR24","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1007\/s00259-021-05603-w","volume":"49","author":"E Guedj","year":"2022","unstructured":"Guedj E, Varrone A, Boellaard R, Albert NL, Barthel H, van Berckel B, et al. EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3. Eur J Nucl Med Mol Imaging. 2022;49:632\u201351. https:\/\/doi.org\/10.1007\/s00259-021-05603-w.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"8093_CR25","doi-asserted-by":"publisher","first-page":"giae049","DOI":"10.1093\/gigascience\/giae049","volume":"13","author":"C Gaser","year":"2024","unstructured":"Gaser C, Dahnke R, Thompson PM, Kurth F, Luders E. The Alzheimer\u2019s Disease Neuroimaging Initiative null. CAT: a computational anatomy toolbox for the analysis of structural MRI data. GigaScience. 2024;13:giae049. https:\/\/doi.org\/10.1093\/gigascience\/giae049.","journal-title":"GigaScience"},{"key":"8093_CR26","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.neuroimage.2006.01.021","volume":"31","author":"RS Desikan","year":"2006","unstructured":"Desikan RS, S\u00e9gonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage. 2006;31:968\u201380. https:\/\/doi.org\/10.1016\/j.neuroimage.2006.01.021.","journal-title":"Neuroimage"},{"key":"8093_CR27","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.jalz.2010.03.006","volume":"6","author":"PS Aisen","year":"2010","unstructured":"Aisen PS, Petersen RC, Donohue MC, Gamst A, Raman R, Thomas RG, et al. Clinical core of the Alzheimer\u2019s Disease Neuroimaging Initiative: progress and plans. Alzheimers Dement. 2010;6:239\u201346. https:\/\/doi.org\/10.1016\/j.jalz.2010.03.006.","journal-title":"Alzheimers Dement"},{"key":"8093_CR28","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1212\/wnl.43.11.2412-a","volume":"43","author":"JC Morris","year":"1993","unstructured":"Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43:2412\u20134. https:\/\/doi.org\/10.1212\/wnl.43.11.2412-a.","journal-title":"Neurology"},{"key":"8093_CR29","doi-asserted-by":"publisher","first-page":"9037","DOI":"10.1002\/alz.14336","volume":"20","author":"LE Collij","year":"2024","unstructured":"Collij LE, Bollack A, La Joie R, Shekari M, Bullich S, Ro\u00e9-Vellv\u00e9 N, et al. Centiloid recommendations for clinical context-of-use from the AMYPAD consortium. Alzheimers Dement. 2024;20:9037\u201348. https:\/\/doi.org\/10.1002\/alz.14336.","journal-title":"Alzheimers Dement"},{"key":"8093_CR30","doi-asserted-by":"publisher","first-page":"e12454","DOI":"10.1002\/dad2.12454","volume":"15","author":"VL Villemagne","year":"2023","unstructured":"Villemagne VL, Leuzy A, Bohorquez SS, Bullich S, Shimada H, Rowe CC, et al. CenTauR: Toward a universal scale and masks for standardizing tau imaging studies. Alzheimers Dement Diagn Assess Dis Monit [Internet]. 2023;15:e12454. https:\/\/doi.org\/10.1002\/dad2.12454. [cited 2026 May 8];.","journal-title":"Alzheimers Dement Diagn Assess Dis Monit [Internet]"},{"key":"8093_CR31","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00259-008-1039-z","volume":"36","author":"L Mosconi","year":"2009","unstructured":"Mosconi L, Mistur R, Switalski R, Tsui WH, Glodzik L, Li Y, et al. FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer\u2019s disease. Eur J Nucl Med Mol Imaging. 2009;36:811\u201322. https:\/\/doi.org\/10.1007\/s00259-008-1039-z.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"8093_CR32","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/978-3-7091-7508-8_8","volume":"54","author":"KA Jellinger","year":"1998","unstructured":"Jellinger KA, Bancher C. Neuropathology of Alzheimer\u2019s disease: a critical update. J Neural Transm Suppl. 1998;54:77\u201395. https:\/\/doi.org\/10.1007\/978-3-7091-7508-8_8.","journal-title":"J Neural Transm Suppl"},{"key":"8093_CR33","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s40478-022-01457-x","volume":"10","author":"GA Marx","year":"2022","unstructured":"Marx GA, Koenigsberg DG, McKenzie AT, Kauffman J, Hanson RW, Whitney K, et al. Artificial intelligence-derived neurofibrillary tangle burden is associated with antemortem cognitive impairment. Acta Neuropathol Commun. 2022;10:157. https:\/\/doi.org\/10.1186\/s40478-022-01457-x.","journal-title":"Acta Neuropathol Commun"},{"key":"8093_CR34","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1001\/archneurol.2011.3029","volume":"69","author":"JL Whitwell","year":"2012","unstructured":"Whitwell JL. Comparison of Imaging Biomarkers in the Alzheimer Disease Neuroimaging Initiative and the Mayo Clinic Study of Aging. Arch Neurol. 2012;69:614. https:\/\/doi.org\/10.1001\/archneurol.2011.3029.","journal-title":"Arch Neurol"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-08093-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-026-08093-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-08093-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T08:32:16Z","timestamp":1790929936000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-026-08093-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["8093"],"URL":"https:\/\/doi.org\/10.1007\/s00259-026-08093-w","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"4 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The ADNI study was approved by the institutional review board or ethics committee at each participating site, and all procedures were conducted in accordance with the ethical standards of the responsible committees and with the Declaration of Helsinki and its later amendments.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all participants or their authorized representatives as part of the ADNI study.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"J.S.R. is a consultant, stakeholder, and member of the board of Qubiotech Health Intelligence S.L., and is additionally a consultant for ZRO Imaging AB. All other authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}